Research and consulting built for oncology decisions
End-to-End Oncology Decision Support
From early opportunity assessment through to post-launch tracking, our services support oncology decisions at every stage — grounded in deep therapeutic expertise and access to the stakeholders who matter most.
Market Opportunity & Demand
TPP / demand assessment — Test and refine target product profiles against real market and stakeholder demand. Market sizing / opportunity evaluation — Quantify the opportunity to inform investment and go-to-market decisions.
Positioning & Value Proposition
Define the positioning and value story that will resonate with oncology's clinical, patient, and system stakeholders.
Concept & Message Testing
Pressure-test concepts and messages with HCPs, KOLs, and patients to maximize communications impact.
ATU & Brand Tracking
Track awareness, trial, and usage over time to understand how your brand is performing relative to competition and uncover new opportunities as perceptions shift.
Omnibus & Express Surveys
Fast, cost-effective access to oncology stakeholder opinion when you need answers quickly.
KOL Consultation & the Oncospective Unit Model
Structured access to oncology key opinion leaders (KOLs), paired with our proprietary Unit Model — the framework we use to convert oncology KOL input into an actionable, quantified result on demand.
Structured KOL access
Access to oncology key opinion leaders paired with a proprietary framework.
Unit Model framework
A framework used to convert oncology KOL input into an actionable, quantified result on demand.
Standardized engagement units
Each engagement is scoped in standardized "units" of KOL input, such as a set number of physician interviews or structured consultations.
Structured results
Clients can size a project from a single expert read to a full panel consultation and know exactly what they are getting back — a structured, comparable result, not a loose set of notes.
Stakeholder access
At the core of our stakeholder access is our in-house, oncology-specific physician panel. We strengthen this with a network of rigorously vetted partners to reach decision-makers and payers.
- HCPs
- KOLs
- System decision-makers
- Payers
- Patients